当前位置:首页 > 股票大全 > 沃华医药 002107 财务分析

沃华医药财务分析

整理编辑:168股票行情网www.gphq168.com    数据来源:互联网 经供参考

沃华医药(002107)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入215,317,031.37909,506,771.72716,392,429.5492,309,107.65
营业总成本207,089,550.94857,005,532.26670,903,250.25462,511,619.01
营业利润10,652,454.3856,489,871.5847,714,006.5931,245,505.45
利润总额10,773,028.6854,638,169.1448,211,892.4731,415,362.12
净利润8,763,449.0546,627,552.246,438,288.7129,564,480.21
其他综合收益----
综合收益总额8,763,449.0546,627,552.246,438,288.7129,564,480.21
沃华医药(002107)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计698,291,664.47673,002,157.76640,141,229.24644,391,739.5
非流动资产合计463,460,689.7471,704,230.82478,882,807.21485,613,656.95
资产总计1,161,752,354.171,144,706,388.581,119,024,036.451,130,005,396.45
流动负债合计297,225,737.4287,990,831.96262,442,521.78286,375,002.04
非流动负债合计22,285,134.1723,237,523.0723,292,744.6124,275,432.85
负债合计319,510,871.57311,228,355.03285,735,266.39310,650,434.89
归属于母公司股东权益合计814,934,549.29805,267,326.06803,901,512.07783,704,228.14
股东权益合计842,241,482.6833,478,033.55833,288,770.06819,354,961.56
负债和股东权益合计1,161,752,354.171,144,706,388.581,119,024,036.451,130,005,396.45
沃华医药(002107)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计254,219,136.071,073,287,004.45826,064,891.56567,765,933.84
经营活动现金流出小计199,731,805.75944,040,140.06734,189,321.59511,840,891.65
经营活动产生的现金流量净额54,487,330.32129,246,864.3991,875,569.9755,925,042.19
投资活动现金流入小计-93,28738,80037,000
投资活动现金流出小计119,485.742,715,422.892,101,222.981,305,292.95
投资活动产生的现金流量净额-119,485.74-2,622,135.89-2,062,422.98-1,268,292.95
筹资活动现金流入小计----
筹资活动现金流出小计-3,553,592.43,456,639.61325,325.6
筹资活动产生的现金流量净额--3,553,592.4-3,456,639.61-325,325.6
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额54,367,844.58123,071,136.186,356,507.3854,331,423.64
期末现金及现金等价物余额453,983,856.82399,616,012.24362,901,383.52330,876,299.78
沃华医药002107相关数据
今日股市大盘指数